HTG MOLECULAR DIAGNOSTICS, INC (CIK: 0001169987) EDGAR, Information, Filings... CompaniesBIO.Com

HTG MOLECULAR DIAGNOSTICS, INC

Mailing address
3430 E. GLOBAL LOOP, TUCSON, Delaware, 85706
Phone
877-289-2615
State location
Arizona
State of incorporation
Delaware
Fiscal year end
December 31
SIC
3826 - (CF Office: Office of Life Sciences) LABORATORY ANALYTICAL INSTRUMENTS
Filings
N/A

HTG MOLECULAR DIAGNOSTICS, INC (CIK: 0001169987) is an American company incorporated in the state of Arizona. Head office is located at 3430 E. GLOBAL LOOP, TUCSON, Arizona, 85706. Work in the industry 3826 - (CF Office: Office of Life Sciences) LABORATORY ANALYTICAL INSTRUMENTS. HTG MOLECULAR DIAGNOSTICS, INC is a public company and trade via Over-The-Counter (OTC).

Old names:

HTG MOLECULAR DIAGNOSTICS INC from 2011-17-Jun to 2012-14-Nov
HIGH THROUGHPUT GENOMICS INC from 2002-01-Mar to 2011-01-Mar

Owner	Filings	Transaction Date	Type of Owner
Barat Stephen	0001965244	Feb-02-2023	officer: Senior VP of Therapeutics
Dubensky Thomas W.	0001635590	Aug-18-2022	director
L5 Capital Inc.	0001869759	Jul-15-2022	10 percent owner
KIRITSY CHRISTOPHER P	0001261156	Jan-27-2022	director
Lawson Byron	0001801387	Jan-23-2020	officer: SVP/Chief Commercial Officer
LYTTON LAURENCE W	0001105806	Sep-20-2019	10 percent owner
Godlewski Laura Lee	0001778044	May-23-2019	officer: VP of Accounting and Reporting
GRIFFIN MICHELLE RENEE	0001229765	Aug-15-2018	director
QIAGEN NV	0001015820	Nov-17-2016	10 percent owner
HANHAM ANN	0001286338	Aug-25-2016	director
HARDISON DON M	0001209588	May-02-2016	director
LAFRANCE JAMES T	0001162956	Dec-01-2015	director
McCracken Lee R.	0001493321	Oct-27-2015	director
GRIMM DONALD W	0001208809	May-11-2015	director
GLAXOSMITHKLINE PLC	0001131399	May-05-2015	10 percent owner
JOHNSON TIM B	0001194674	May-05-2015	director, officer: President & CEO
McMeans Shaun D	0001316705	May-05-2015	officer: VP, Finance & Admin. & CFO
FSV II LP	0001384327	May-05-2015	10 percent owner
Fletcher Spaght Ventures II LP	0001384348	May-05-2015	10 percent owner
Novo A/S	0001388325	May-05-2015	10 percent owner
FSV II-B LP	0001433420	May-05-2015	10 percent owner
Shuster Lewis	0001471131	May-05-2015	director
George Simeon	0001595117	May-05-2015	director
Bisgaard Peter	0001606387	May-05-2015	director
Senour Lawrence D.	0001623206	May-05-2015	10 percent owner
Hoult Mary	0001623212	May-05-2015	director
Roche Patrick C.	0001623213	May-05-2015	officer: SVP Research & Development
Gordon Debra A	0001623214	May-05-2015	officer: V.P. and Chief Legal Counsel
Merck Capital Ventures LLC	0001623584	May-05-2015	10 percent owner
Lubniewski John L	0001623587	May-05-2015	officer: Chief Business Officer
George Harry A.	0001628346	May-05-2015	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by HTG MOLECULAR DIAGNOSTICS, INC

Filings	Format	Description	Filed/Effective	File/Film Number
25-NSE	Document	Acc-no: 0001354457-23-000488 (34 Act) Size: KB	Jul-10-2023	001-37369
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-036100 ( Act) Size: 0 KB	Jun-09-2023
8-K	Document	Current report filing Acc-no: 0000950170-23-027044 (34 Act) Size: KB	Jun-08-2023	001-37369 231002645
8-K	Document	Current report filing Acc-no: 0000950170-23-026337 (34 Act) Size: KB	Jun-05-2023	001-37369 23992277
8-K	Document	Current report filing Acc-no: 0000950170-23-023963 (34 Act) Size: KB	May-24-2023	001-37369 23954940
8-K	Document	Current report filing Acc-no: 0000950170-23-022358 (34 Act) Size: KB	May-16-2023	001-37369 23925724
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-23-020725 (34 Act) Size: KB	May-11-2023	001-37369 23908257
8-K	Document	Current report filing Acc-no: 0000950170-23-020671 (34 Act) Size: KB	May-10-2023	001-37369 23907806
8-K	Document	Current report filing Acc-no: 0000950170-23-014248 (34 Act) Size: KB	Apr-25-2023	001-37369 23841800
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-023774 ( Act) Size: 0 KB	Apr-07-2023
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-23-010975 (34 Act) Size: KB	Mar-30-2023	001-37369 23781154
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000935836-23-000183 (34 Act) Size: KB	Feb-13-2023	005-88837 23617793
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001209191-23-008420 ( Act) Size: 0 KB	Feb-10-2023
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000919574-23-000851 (34 Act) Size: KB	Feb-10-2023	005-88837 23608764
8-K	Document	Current report filing Acc-no: 0000950170-23-001781 (34 Act) Size: KB	Feb-03-2023	001-37369 23586472
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000890163-23-000011 (34 Act) Size: KB	Feb-03-2023	005-88837 23585685
8-K	Document	Current report filing Acc-no: 0000950170-23-000286 (34 Act) Size: KB	Jan-06-2023	001-37369 23513806
8-K	Document	Current report filing Acc-no: 0000950170-22-027080 (34 Act) Size: KB	Dec-29-2022	001-37369 221496349
8-K	Document	Current report filing Acc-no: 0000950170-22-027014 (34 Act) Size: KB	Dec-23-2022	001-37369 221485723
424B4	Document	Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001193125-22-311164 (33 Act) Size: KB	Dec-22-2022	333-268681 221482694

Recent 20 filings. View all HTG MOLECULAR DIAGNOSTICS, INC filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

HTG MOLECULAR DIAGNOSTICS, INC overview
HTG MOLECULAR DIAGNOSTICS, INC job
HTG MOLECULAR DIAGNOSTICS, INC stock
HTG MOLECULAR DIAGNOSTICS, INC ownership
HTG MOLECULAR DIAGNOSTICS, INC CEO
HTG MOLECULAR DIAGNOSTICS, INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.